Literature DB >> 29216591

Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.

Yu Sun1, Henrik Jensen2, Nickolaj J Petersen3, Susan W Larsen4, Jesper Østergaard5.   

Abstract

For poly (lactide-co-glycolide acid) (PLGA)-based in situ forming implants, the rate of implant formation plays an important role in determining the overall drug release kinetics. Currently, in vitro techniques capable of characterizing the processes of drug release and implant formation at the same time are not available. A hydrogel-based in vitro experimental setup was recently developed requiring only microliter of formulation and forming a closed system potentially suitable for interfacing with various spectroscopic techniques. The aim of the present proof-of-concept study was to investigate the feasibility of concomitant UV imaging, Vis imaging and light microscopy for detailed characterization of the behavior of in situ forming PLGA implants in the hydrogel matrix mimicking the subcutis. The model compounds, piroxicam and α-lactalbumin were added to PLGA-1-methyl-2-pyrrolidinone and PLGA-triacetin solutions. Upon bringing the PLGA-solvent-compound pre-formulation in contact with the hydrogel, Vis imaging and light microscopy were applied to visualize the depot formation and UV imaging was used to quantify drug transport in the hydrogel. As compared to piroxicam, the α-lactalbumin invoked an acceleration of phase separation and an increase of implant size. α-Lactalbumin was released faster from the PLGA-1-methyl-2-pyrrolidinone system than the PLGA-triacetin system opposite to the piroxicam release pattern. A linear relationship between the rate of implant formation and initial compound release within the first 4h was established for the PLGA-NMP systems. This implies that phase separation may be one of the controlling factors in drug release. The rate of implant formation may be an important parameter for predicting and tailoring drug release. The approach combining UV imaging, Vis imaging and light microscopy may facilitate understanding of release processes and holds potential for becoming a useful tool in formulation development of in situ forming implants.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug release; Implant formation; Phase separation; UV imaging; Vis imaging; in situ forming PLGA implants

Mesh:

Substances:

Year:  2017        PMID: 29216591     DOI: 10.1016/j.jpba.2017.11.065

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Noninvasive characterization of in situ forming implant diffusivity using diffusion-weighted MRI.

Authors:  Kelsey A Hopkins; Nicole Vike; Xin Li; Jacqueline Kennedy; Emma Simmons; Joseph Rispoli; Luis Solorio
Journal:  J Control Release       Date:  2019-07-16       Impact factor: 9.776

2.  Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.

Authors:  Jan Kozak; Miloslava Rabiskova; Alf Lamprecht
Journal:  AAPS PharmSciTech       Date:  2021-03-29       Impact factor: 3.246

Review 3.  Employing hydrogels in tissue engineering approaches to boost conventional cancer-based research and therapies.

Authors:  Javad Esmaeili; Abolfazl Barati; Jafar Ai; Vajihe Taghdiri Nooshabadi; Zeynab Mirzaei
Journal:  RSC Adv       Date:  2021-03-12       Impact factor: 3.361

Review 4.  Mass spectrometry-based metabolomics in health and medical science: a systematic review.

Authors:  Xi-Wu Zhang; Qiu-Han Li; Zuo-di Xu; Jin-Jin Dou
Journal:  RSC Adv       Date:  2020-01-17       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.